KNSA
Kiniksa Pharmaceuticals Ltd.
$36.08
+$0.66(+1.86%)
62
Overall
35
Value
90
Tech
--
Quality
Market Cap
$2.62B
Volume
267.06K
52W Range
$17.82 - $37.34
Target Price
$43.00
EPS Estimates Overview
| Current Quarter | $0.31 | Next Quarter | $0.37 |
| Current Year | $1.03 | Next Year | $1.6 |
| QoQ Growth | +19.4% | YoY Growth | +55.3% |
| 3Y EPS CAGR | +36.1% | Target Price | $43.00 |
| Consensus | Buy | Upside | +19.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $36.08 | +1.9% | 267.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW